USPTO serial 97611312
Serial No. 97611312
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 21, 2024
- Examiner
- ROACH, APRIL K
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 97611312?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rajesh Fotedar
Rajesh Fotedar COGNITION IP P.C.50 California St., Suite 1500San Francisco, CA 94111United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Preparations for the relief of conditions caused by atopy for oral delivery and topical administration, namely, pharmaceutical preparations for developing tolerance to allergens; Preparations for the relief of allergies customized for a patient based on results from the patient's allergy tests, namely, pharmaceutical preparations for developing tolerance to allergens; Preparations for the relief of allergies customized for a patient based on results from the patient's at-home allergy tests, namely, pharmaceutical preparations for developing tolerance to allergens; Patient-customized preparations for the relief of allergies, namely, pharmaceutical preparations for developing tolerance to allergens; Patient-customized preparations for the relief of conditions caused by atopy for oral delivery and topical administration, namely, pharmaceutical preparations for developing tolerance to allergens; At-home allergy test kits comprised of medical diagnostic test patches for detecting allergen-specific immunoglobulin E (IgE) antibodies in blood samples in order to determine allergic reactions; Direct-to-consumer allergy test kits comprised of medical diagnostic test patches for detecting allergen-specific immunoglobulin E (IgE) antibodies in blood samples in order to determine allergic reactions for the purpose of obtaining information for customized preparations for the relief of allergies; Direct-to-consumer allergy test kits comprised of medical diagnostic test patches for detecting allergen-specific immunoglobulin E (IgE) antibodies in blood samples in order to determine allergic reactions for the purpose of obtaining information for customized pharmaceutical preparations for developing tolerance to allergens | ACTIVE | — |
| 044 | Telemedicine services and telemedicine treatment services for treatment of conditions caused by atopy, namely, for determining a treatment plan with prescription allergy medication in a formulation customized according to results of a patient's allergy test; Telemedicine services and telemedicine treatment services for treatment of conditions caused by atopy, namely, for determining a treatment plan with prescription allergy medication in a formulation customized according to results of a patient administered allergy test; Telemedicine services and telemedicine treatment services for treatment of conditions caused by atopy, namely, for determining a treatment plan with prescription allergy medication in a formulation customized according to results of a patient's at home allergy test; Telemedicine services and telemedicine treatment services for treatment of conditions caused by atopy, namely, for determining a treatment plan with prescription allergy medication in a formulation customized according to results of a patient's direct-to-consumer allergy test; Telemedicine services and telemedicine treatment services for treatment of conditions caused by atopy, namely, information regarding a treatment plan with customized pharmaceutical preparations for developing tolerance to allergens | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 21, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 21, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 18, 2024 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Apr 17, 2024 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Apr 13, 2024 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Apr 12, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 22, 2024 | IUAF | USE AMENDMENT FILED | — |
| Mar 22, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Mar 19, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 23, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 23, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 3, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 18, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 13, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 12, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 12, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Dec 12, 2023 | RDX3 | NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED | — |
| Dec 12, 2023 | RDX1 | ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED | — |
| Dec 12, 2023 | RRDX | ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED | — |
| Dec 8, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 7, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 7, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 16, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 16, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 16, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 13, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 12, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 12, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 13, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 13, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 13, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 12, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 18, 2022 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Oct 16, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 1, 2022 | NWAP | NEW APPLICATION ENTERED | — |